â??To study the effectiveness of Ivermectin with standard of care treatmentversus standard of care treatment for COVID 19 cases. A Pilot Study
Not Applicable
- Conditions
- Health Condition 1: B338- Other specified viral diseases
- Registration Number
- CTRI/2020/04/024858
- Lead Sponsor
- Max Super Speciality Hospital A Unit of Devki Devi Foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Subjects within age group between 18 to 75 years
2. With either sex, male or female
3. Confirmed case of COVID-19 at Max Hospitals.
Exclusion Criteria
Patients who are critically sick
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method This study aims to confirm the antivirus effectiveness of Ivermectin on coronavirus i.e COVID 19 <br/ ><br>then to explore its potential use in the combating to the COVID 19 pandemics.Timepoint: Viral load will be monitored at 1, 3 & 5 days from beginning of trial drug (48 hours interval) Until the report comes negative. Drug will be delivered on daily basis upto eradication of virus or completion of <br/ ><br>the trial
- Secondary Outcome Measures
Name Time Method Safety of the drug vs standard care of treatment will be checkedTimepoint: Treatment will be provided until the eradication of virus or completion of <br/ ><br>the trial.